PointCross Logo
PointCross Releases eDataValidator for SDTM, ADaM, SEND, and Define.XML Conformance to Prevailing FDA, CDISC, and PMDA Rules
July 20, 2022 09:00 ET | PointCross Life Sciences
FOSTER CITY, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- PointCross Life Sciences announced today the full complement release of its eDataValidator™ (eDV) for validating SDTM, ADaM, SEND and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021
December 07, 2021 16:03 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Completes Purchase of Envigo
November 05, 2021 13:33 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contract research organization (CRO) specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purchase Additional $15 Million of Notes
September 27, 2021 16:05 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering
September 22, 2021 18:34 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering
September 21, 2021 17:05 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical...
Inotiv_Logo_CMYK.png
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
September 21, 2021 09:00 ET | Inotiv, Inc.
-- Expected to establish a leading global provider of a full spectrum of pre-clinical solutions -- -- Expected to be immediately accretive to Inotiv earnings and margins before synergies -- --...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Third Quarter Fiscal 2021 Financial Results
August 11, 2021 16:05 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio
July 12, 2021 08:33 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., July 12, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Nicolette Jackson Photo
Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort
June 28, 2021 08:33 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., June 28, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...